Teva Canada Product Recall (2018-11-23)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 35439807A | B. Novamoxin Granules for Oral Suspension 250mg/5mL | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Granules for suspension | DIN 00452130 | Amoxicillin 250mg/5mL |
| 35438292B, 35438811A | A. Novamoxin Granules for Oral Suspension 125mg/5mL | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Granules for suspension | DIN 00452149 | Amoxicillin 125mg/5mL |
Recalled Product
A. Novamoxin Granules for Oral Suspension 125mg/5mL
B. Novamoxin Granules for Oral Suspension 250mg/5mL
Out of specification results for homogeneity.